What is the market doing?
What the tape says about GILD
Gilead Sciences is +38% over the past year while the S&P 500 is +23%: 15 points ahead of the market.
+38%
1-year return · S&P 500 +23%
- vs 200-day average
- +13%
vs 200-day average · a clear uptrend
- RSI (14)
- 82
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −3.8%
Below its 52-week high
Details›
- Last close2026-08-26
- $148.13
- 1 monthS&P 500 +3.7%
- +13%
- 1 yearS&P 500 +23%
- +38%
- 5 yearsS&P 500 +87%
- +160%
- vs 50-day average$132.54
- +12%
- 52-week high
- $153.91
- 52-week low
- $107.48
- Annualised volatility
- 27%
| Year | Return |
|---|---|
| 2026 (year to date) | +22% |
| 2025 | +37% |
| 2024 | +19% |
| 2023 | −2.0% |
| 2022 | +24% |
| 2021 | +30% |
| 2020 | −6.7% |
| 2019 | +7.9% |
| 2018 | −9.9% |
| 2017 | +3.0% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +5.0% |
| Feb | 10 | 3 of 10 | −1.4% |
| Mar | 10 | 5 of 10 | +0.89% |
| Apr | 10 | 3 of 10 | −1.6% |
| May | 10 | 4 of 10 | −1.2% |
| Jun | 10 | 7 of 10 | +3.1% |
| Jul | 11 | 5 of 11 | +1.3% |
| Aug | 11 | 7 of 11 | +2.4% |
| Sep | 10 | 4 of 10 | −0.17% |
| Oct | 10 | 5 of 10 | +0.52% |
| Nov | 10 | 8 of 10 | +4.0% |
| Dec | 10 | 3 of 10 | −1.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - General
Ranks #6 of 16 by Smart Score